Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/AR/Fayetteville
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Fayetteville, AR

Studies commonly pay $75 to $4,500 per completed study

126 clinical trials are currently recruiting participants within 30 miles of Fayetteville. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

126studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Fayetteville right now

Top 25 of 126 recruiting studies, sorted by proximity — each links to its official registry page

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma Phase 2 Interventional 396 participants sought
Highlands Oncology Group - Fayetteville — Fayetteville, Arkansas (0.8 mi) · Sponsor: SWOG Cancer Research Network

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

Locally Advanced Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 1,145 participants sought
Research Site — Springdale, Arkansas (8.2 mi) · Sponsor: AstraZeneca

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer Phase 3 Interventional 1,000 participants sought
Highlands Oncology Group, PA — Fayetteville, Arkansas (0.8 mi) · Sponsor: Pfizer

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer Phase 3 Interventional 1,410 participants sought
Highlands Oncology Group — Fayetteville, Arkansas (0.8 mi) · Sponsor: Pfizer

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought
Highlands Oncology Group - Fayetteville — Fayetteville, Arkansas (0.8 mi) · Sponsor: National Cancer Institute (NCI)

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

NonSegmental Vitiligo Phase 3 Interventional 180 participants sought
Premier Dermatology Clinical Trials Institute At Northwest Arkansas — Fayetteville, Arkansas (0.8 mi) · Sponsor: Incyte Corporation

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought
Highlands Oncology Group - Fayetteville — Fayetteville, Arkansas (0.8 mi) · Sponsor: National Cancer Institute (NCI)

Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder

Cannabis Withdrawal Phase 3 Interventional 420 participants sought
Woodland Research Northwest, LLC — Rogers, Arkansas (18.2 mi) · Sponsor: PleoPharma, Inc.

Physical Activity and Community EmPOWERment Project

Intellectual Disability, Neurodevelopmental Disorders N/A Interventional 376 participants sought
University of Arkansas — Fayetteville, Arkansas (0.8 mi) · Sponsor: University of North Carolina, Chapel Hill

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung Phase 3 Interventional 700 participants sought
Highlands Oncology Group — Springdale, Arkansas (8.2 mi) · Sponsor: Eli Lilly and Company

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma Phase 3 Interventional 700 participants sought
Highlands Oncology Group — Springdale, Arkansas (8.2 mi) · Sponsor: Janssen Research & Development, LLC

JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

AAA, AAA - Abdominal Aortic Aneurysm N/A Interventional 450 participants sought
Washington Regional Medical Center — Fayetteville, Arkansas (0.8 mi) · Sponsor: Endologix

A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)

Muscle-invasive Urothelial Carcinoma Phase 2 Interventional 62 participants sought
Highlands Oncology Group. — Springdale, Arkansas (8.2 mi) · Sponsor: Hoffmann-La Roche

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

Bipolar Disorder Type I With Mania or Mania With Mixed Features Phase 3 Interventional 274 participants sought
Woodland Research Northwest — Rogers, Arkansas (18.2 mi) · Sponsor: Bristol-Myers Squibb

A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer

Platinum-resistant Ovarian Cancer Phase 1 Interventional 100 participants sought
Highlands Oncology Group — Springdale, Arkansas (8.2 mi) · Sponsor: Stemline Therapeutics, Inc.

GAINS Expert Guiding Technology to Coach Life Skill Teaching

GAINS Expert Guiding Technology to Coach Life Skill Teaching N/A Interventional 24 participants sought
University of Arkansas — Fayetteville, Arkansas (0.8 mi) · Sponsor: Guiding Technologies Corporation

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD Phase 3 Interventional 284 participants sought
Adverum Clinical Site 198 — Springdale, Arkansas (8.2 mi) · Sponsor: Adverum Biotechnologies, Inc.

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer Phase 3 Interventional 1,160 participants sought
Research Site — Springdale, Arkansas (8.2 mi) · Sponsor: AstraZeneca

Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age

Pneumococcal Immunization, Healthy Volunteers Phase 3 Interventional 2,195 participants sought
Northwest Arkansas Pediatric Clinic- Site Number : 8400039 — Fayetteville, Arkansas (0.8 mi) · Sponsor: Sanofi

A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab

B-Cell ALL, B-Cell Acute Lymphoblastic Leukaemia N/A Observational 300 participants sought
Arkansas Children's Northwest — Springdale, Arkansas (8.2 mi) · Sponsor: Arkansas Children's Hospital Research Institute
Actively enrolling

Studies you may be able to join near Fayetteville

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Fayetteville

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Health Initiatives Research

2233 Green Acres Rd, Fayetteville, AR 72703
(479) 575-9600

Clinical Trials Institute of Northwest Arkansas

1651 E Stearns St #110, Fayetteville, AR 72703
(479) 544-3483

UAMS Northwest Regional Campus

★ 3.8
1125 N College Ave, Fayetteville, AR 72703
(479) 713-8000

The Spero Clinic

★ 4.9 (242 reviews)
22 Colt Square Dr, Fayetteville, AR 72703
(479) 333-8422

Woodland Research Northwest

★ 4.3
609 W Dyke Rd, Rogers, AR 72758
(479) 927-3000

Pat Walker Health Center

★ 3.0
525 Garland Ave, Fayetteville, AR 72701
(479) 575-4451
"The ladies at the front desk are very welcoming and friendly. They are very outgoing and were more than happy to help me. I really appreciate the tim…"
— Miller Johnston, 5★

Pillar Clinical Research, Bentonville, Arkansas

★ 4.9
3200 NE Redhawk Dr, Bentonville, AR 72712
(479) 367-2688
"⭐⭐⭐⭐⭐<br><br>I had a great experience with Pillar Clinical Research. The staff was friendly, professional, and made me feel comfortable from the…"
— elexis Thomas, 5★

C & C Market Research

★ 4.1
4201 N Shiloh Dr #1820, Fayetteville, AR 72703
(479) 582-1127
"Tried calling the number says been disconnected ☹️😡"
— Elizabeth Ritcheson (Bettyjo), 1★

Northwest Arkansas Clinical Trials Center, PLLC

★ 5.0
599 S Horsebarn Rd #200, Rogers, AR 72758
(479) 876-8205

Clinical trials in Fayetteville: what's recruiting

The Fayetteville area currently has 126 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Fayetteville, the most active research areas are:

  • Cancer & Oncology12 studies
  • Brain & Mental Health2 studies
  • Immune & Skin1 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Fayetteville, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Fayetteville

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Fayetteville participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Fayetteville pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Fayetteville safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Fayetteville?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Fayetteville.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Fayetteville typically complete one or two studies per year.

Paid clinical trials near Fayetteville

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of AR

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts